Azetidine

Azetidine

SCHEMBL790780

C1CNC1.CN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azetidine SCHEMBL27529230 1.00 CXCR4 (0.50)
Pyrrolidine SCHEMBL11882125 0.91
Pyrrolidine SCHEMBL27804270 0.91 ALDH1A1 (0.67)
Methylamine SCHEMBL3131654 0.87 ALDH1A1 (0.75)
Piperidine SCHEMBL9953296 0.87
Piperidine SCHEMBL28822666 0.83
Piperidine SCHEMBL28192599 0.83 ALDH1A1 (0.69)
Azetidine SCHEMBL5364501 0.82
Aziridine SCHEMBL27795549 0.82
Azetidine SCHEMBL12502 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130196971-A1 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2013-08-01 US disclosed
EP-2615918-A1 FATTY ACID SYNTHASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2013-07-24 EP disclosed
WO-2012037298-A1 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed